STAT+: Roche goes beyond licensing in deal with Chinese biotech

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Roche goes beyond licensing in deal with Chinese biotechWorldPing
Image via STAT.

What happened

Roche is partnering with Chinese startup Defand Therapeutics to discover new medicines.

Key facts

  • Reported by STAT and published Thu, 08 Oct 2026 15:18:05 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

  2. STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more

  3. STAT+: Roche goes beyond licensing in deal with Chinese biotech

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage